[ad_1] Novartis said in August that it plans to spin off its generics unit Sandoz to sharpen its focus on…
Read More »Breaking News: Investing
[ad_1] Evercore ISI initiated coverage of Aclaris Therapeutics , a clinical stage biotech working on immunology and inflammation drugs, at…
Read More »